Company Profile

Aktiv-Dry LLC
Profile last edited on: 9/2/2023      CAGE: 3MHQ2      UEI: XKXUNMZJMKJ8

Business Identifier: Development of vaccines that can be stored dry and inhaled
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2100 Central Avenue Suite 109
Boulder, CO 80301
   (303) 350-3060
Location: Single
Congr. District: 02
County: Boulder

Public Profile

AKTIV-DRY LLC, a spin-out company formed from University of Colorado, provides dry powder stabilization and processing solutions for the vaccine, pharmaceutical, and biotechnology industries. The company is particularly interested in particle stabilization, synthesis, drying and coating technologies. AKTIV-DRY has a proven track record in micronizing and gently drying vaccines, antibodies, enzymes, proteins and other pharmaceutical compounds. AKTIV-DRY engineers particle sizes and morphology to satisfy your requirements. Licenses are available for the patents and intellectual property shown on the page with that name. The firm is trying to develop a measles vaccine that can be stored dry and inhaled which turns it into glassy particles surrounding a matrix of trehalose, the sugar that allows brine shrimp cysts to survive dried out for years but hatch into wriggling creatures in seawater.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Brian Quinn -- President

  Stephen P Cape -- Chief Scientific Officer

  Pankaj Pathak -- Research Scientist

  James Arthur Searles

  Robert E Sievers -- Chief Executive Officer